Aquablation Procedure Safe for BPH, With Durable Efficacy
Significant improvement seen in patient symptoms at 5 years; improvement also seen in mean maximum urinary flow rate
Significant improvement seen in patient symptoms at 5 years; improvement also seen in mean maximum urinary flow rate
5α-reductase inhibitors are widely used to treat lower urinary tract symptoms in men with benign prostatic hyperplasia (BPH).
Some studies show that use of transurethral resection of the prostate, long the gold standard for managing enlarged prostates, is in decline, but it still remains the most popular choice among surgeons amid a wide range of options.
In less than 3 months after procedure, only mild urinary symptoms reported; benefits persisted through 6 years
Average video score was 6.65; only 24.3% of videos emphasized critical steps of surgery
This Swedish population-based study has the largest sample size to date exploring these associations.
Association especially strong among the elderly male population
TG/HDL-C and TC/HDL-C ratios associated with BPH; TG/HDL-C may be risk factor for BPH with normal TG, HDL-C
By identifying existing medications that may be repurposed for dementia, clinicians may be able to provide faster treatment for those in need.
But rate of retrograde ejaculation higher following many surgical procedures for benign prostatic hyperplasia